A detailed history of Tiedemann Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 73,388 shares of PRCT stock, worth $6.14 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
73,388
Previous 86,236 14.9%
Holding current value
$6.14 Million
Previous $3.05 Million 21.03%
% of portfolio
0.1%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$30.02 - $38.81 $385,696 - $498,630
-12,848 Reduced 14.9%
73,388 $2.41 Million
Q2 2022

Aug 03, 2022

BUY
$29.23 - $44.45 $2.52 Million - $3.83 Million
86,236 New
86,236 $2.82 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.73B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Tiedemann Advisors, LLC Portfolio

Follow Tiedemann Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.